See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Stock Markets
Trade War
Social Media
Donald Trump
Natural Disasters
US Economy
Recession
Artificial Intelligence
Trade
Soccer
Published • loading... • Updated

Using ultrasound and bubbles to destroy tumours: New cancer treatment to be trialled in Singapore

Summary by The Straits Times
Li Ka Shing Foundation and Temasek Trust have committed $12 million to conduct histotripsy trials here. Read more at straitstimes.com.

7 Articles

All
Left
Center
Right
1
The Straits TimesThe Straits Times
Lean Right

Using ultrasound and bubbles to destroy tumours: New cancer treatment to be trialled in Singapore

Li Ka Shing Foundation and Temasek Trust have committed $12 million to conduct histotripsy trials here. Read more at straitstimes.com.

·Singapore
Read Full Article
TechNode GlobalTechNode Global

Li Ka Shing Foundation, Temasek Trust jointly commit $9M to acquire systems and advance clinical trial for innovative histotripsy cancer therapy in Singapore

The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million ($8.99 million) to bring innovative non-invasive ultrasound-based histotripsy tumor clinical trials to Singapore. The duo said in a statement on Friday that the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) will each receive one Histotripsy System – the first of such to be available in Southeast Asia. The …

Read Full Article
European Business MagazineEuropean Business Magazine

Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore - European Business & Finance Magazine

SINGAPORE - Media OutReach Newswire - 04 April 2025 - The Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) have committed S$12 million to bring innovative

Read Full Article
Brand SpurBrand Spur

Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore - Brand Spur

Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) in Singapore to perform clinical trials to study novel ultrasound therapy for liver, kidney and pancreatic cancers. The funding from LKSF and TT will be disbursed through a Donor-Advised Fund managed by TT Foundation Advisors (TTFA), …

Read Full Article
Macau BusinessMacau Business
+2 Reposted by 2 other sources

Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore

Li Ka Shing Foundation (LKSF) and Temasek Trust (TT) are purchasing and donating two Histotripsy Systems to the National Cancer Centre Singapore (NCCS) and the National University Cancer Institute, Singapore (NCIS) in Singapore to perform clinical trials to study novel ultrasound therapy for liver, kidney and pancreatic cancers. The funding from LKSF and TT will be disbursed through a Donor-Advised Fund managed by TT Foundation Advisors (TTFA), …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Straits Times broke the news in Singapore on Thursday, April 3, 2025.
Sources are mostly out of (0)

Similar News Topics

Asia

Asia

Singapore, Singapore

Singapore, Singapore

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal